Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. (ORMP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ORMP · as of Jun 9, 2026
Key Statistics
Explore Oramed Pharmaceuticals Inc. Data
ormp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 75.0%
Competitors & Peers
ormp competitorsORMP
CLNN
CNTB
CNTX
COYA
IFRXStock Performance
Full HistoryAbout Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally inge…
what is oramed pharmaceuticals inc. · ormp stock overview · oramed pharmaceuticals inc. company profile · who is oramed pharmaceuticals inc. ceo · ormp NASDAQ · oramed pharmaceuticals inc. headquarters · oramed pharmaceuticals inc. business segments
About Stock Overview & Key Data
Oramed Pharmaceuticals Inc. (ORMP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 1, 2007. As of the latest trading session, ORMP stock price is $3.64, with a market capitalization of $149.0M. The stock has returned +63.23% over the past 12 months and +27.72% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Oramed Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Oramed Pharmaceuticals Inc. reported revenue of $2.0M and net income of $64.0M. For detailed data — including Oramed Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Oramed Pharmaceuticals Inc. (ORMP) stock price is $3.64. The stock is traded on NASDAQ under the ticker symbol ORMP. The 52-week range is $1.98 – $5.01.